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Background: The current COVID-19 pandemic has affected almost 17.3 million victims worldwide with mortality 
of almost 674K. Pregnancy is one of the most susceptible conditions for COVID-19 infection, but limited data is 
currently available about the clinical characteristics of pregnant women with the disease. Objective; to describe 
the clinical characteristics, co-morbidities, management, feto-maternal, and neonatal outcome in COVID-19 
positive pregnant women.  
Methodology: A descriptive case series study was conducted in Obs/Gynae dept of Benazir Bhutto Tertiary Care 
Hospital, Rawalpindi, including all asymptomatic/symptomatic COVID-19 positive pregnant women and clinical 
suspects (COVID-19 PCR negative women) delivered in our hospital from 01st April 2020 to 31st July 2020. Their 
medical records were reviewed for clinical characteristics, management, feto-maternal and neonatal outcomes. 
Continuous variables were expressed in Mean & Range and Categorical variables as number & Percentage. 
Results: During the study period a total of 17 cases were reviewed. The mean maternal age was 28.94 yrs. 
Primigravida (07), Multipara (10). Mean gestational age was 37 wks (range; 30-41wks). Presenting 
symptomatology was varied. Asymptomatic; (29%), COVID-19 specific symptoms; fever & flu (12%), 
fever&cough (6%), shortness of breath(SOB) alone (6%), fever & SOB(6%) and pregnancy-related manifestations 
were labour pains (17%), eclampsia(6%), hydrocephalous fetus (6%) and hepatic encephalopathy(6%). The 
commonest co-morbidity was Hypertensive disorders of pregnancy (24%). Five women (29%) required ICU care. 
Lower segment caesarean sections(LSCS) (59%), vaginal delivery (41%). Eleven babies delivered with good Apgar 
score and birth weight. Two were early neonatal deaths (ENND) and 04 were received intra-uterine fetal deaths 
(IUDs). Fetal demise was associated with strong obstetric risk factors. Out of 13 live-born babies, RT-PCR Covid-
19 testing was done in 10 (77%) cases and was negative. One mother was expired due to complications of hepatic 
encephalopathy, sepsis, and burst abdomen.  
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Conclusion; The clinical course of COVID-19 disease in pregnancy seems to be no different from non-pregnant 
women. Clinical manifestations are diverse and infection contracted in the third trimester of pregnancy is 
associated with good feto-maternal and neonatal outcomes. 





The current Coronavirus infection 2019 (COVID-19) 
caused by the novel severe acute respiratory 
syndrome coronavirus 2 (SARS-C0V-2)1 has been 
declared as a Pandemic by WHO on 11th March 2010.2 
The first reported case was in December 2019 in 
Wuhan city, Hubei province of China.3 Since then it 
has affected almost 17.3 million victims worldwide 
with mortality of almost 674K. In Pakistan, till now 
278 K positive cases and 5.9K deaths have been 
reported.4  
This highly contagious disease with the main 
predilection for pulmonary system spreads by 
respiratory droplets during coughing, sneezing and 
close physical contact.5-7 The most susceptible 
population is believed to be elderly people (>65yrs), 
people with chronic disease, or an immuno-
compromised condition.7,8 Being an immuno-
compromised state, pregnancy is believed to be an 
important risk factor for COVID-19 infection.9,10 Both 
pregnancy and COVID-19 infection share the same 
immune response characterized by a decrease in 
lymphocytes and an increase in certain pro-
inflammatory cytokines.11,12 Furthermore, placental 
villi have angiotensin-converting enzyme-2 (ACE2) 
receptors through which coronavirus enters the host 
cells. These receptors can also facilitate the vertical 
transmission of infection.10 
As infection is a rise in the general population so are 
the pregnant women too at more risk. Almost 15,735 
pregnant women with laboratory-confirmed infection 
and 37 deaths have been reported in the United States 
alone.13 There is a paucity of knowledge regarding 
various aspects of this novel virus disease. Since the 
start of the pandemic, multiple studies are being 
carried out to understand its clinical manifestations 
and management not only in the general population 
but also in special conditions like pregnancy. Index 
study was plotted with the same aim to contribute to a 
globally gathered pool of obstetric knowledge and 
management plan in COVID-19 positive pregnant 
women. Our hospital is “Exclusive COVID-19 
Management” declared hospital by the government of 
Punjab and our obstetric department has been 
managing COVID-19 positive pregnant women since 
the start of this pandemic in the region. In this study, 
we are sharing our experience regarding the clinical 
presentation, management, feto-maternal and neonatal 
outcome of COVID-19 positive pregnant women. This 
will be a beneficial data for other tertiary maternity 
care hospitals which are managing pregnant women 
in this pandemic.  
 
Material and Methods 
 
Study Design, Setting and Material 
This single centered, descriptive case series study was 
carried out in the Obstetrics & Gynaecology 
department of “exclusive COVID-19 management 
designated” Benazir Bhutto Tertiary Care Hospital, an 
Allied teaching hospital of Rawalpindi Medical 
University, Pakistan. After approval of the 
institutional ethical committee, we reviewed the 
medical records of all symptomatic/asymptomatic 
confirmed Reverse transcriptase-polymerase chain 
reaction (RT-PCR) COVID-19 positive pregnant 
women and strong clinical suspects with RT-PCR 
COVID-19 negative status and managed in our 
obstetrics department from 1st April’ 2020 to 31st July’ 
2020. There was no exclusion criterion. Whether 
women were our booked/Non-booked or referred 
from other health facilities, medical charts of all were 
reviewed.  
Method/Procedure; After admission, the SARS-COV-2 
status of all affected women was reconfirmed by a 
hospital designated experienced healthcare personnel, 
who took nasopharyngeal swabs for real-time RT-PCR 
using WHO guidelines. There was a designated labour 
room, operation theatre, and ward for managing pre-
natal and post-natal mothers. Though per 
departmental policy, there was a low threshold for 
caesarean delivery for COVID-19 positive women 
those who presented in an active phase of labour or 
multigravida with good bishop score were encouraged 
to deliver vaginally. At birth, babies were promptly 
attended by a paediatrician and then transferred to a 
neonatal isolation room for further needful 
management, and COVID-19 testing after 24hrs was 
done as per the policy of paediatric department. 
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Mothers were discharged once they were 
afebrile/stable and had two consecutive negative RT-
PCR tests 24 hrs apart after approval of a 
multidisciplinary team comprising of an obstetrician, 
anaesthetist, and medical specialist/pulmonologist. 
Maternal and neonatal status at the time of discharge 
was recorded on medical charts. Completed charts 
were saved and later on reviewed for the study 
descriptive outcome variables like; demographic 
profile, clinical presentation, co-morbidities, maternal 
obstetric complications, management plan (mode of 
delivery), feto-maternal and neonatal outcome during 
a hospital stay. Neonatal outcome was measured in 
terms of mortality and morbidity like; compromised 
birth Apgar score, baby weight, admission to NICU, 
COVID-19 vertical transmission. All data were 
recorded on a specially designed proforma.  
Statistical Analysis: Data was entered on SPSS version 
22. Continuous variables were expressed in Mean & 





During the study period total of seventeen (n=17) 
medical charts were reviewed. Fourteen (n=14) 
pregnant women were confirmed COVID-19 positive 
on repeat RT-PCR testing while 03 were COVID-19 
negative, but being strong clinical suspects they were 
managed as COVID-19 positive and included in the 
study. The first case was admitted on 18th April 2020 
and the last one on 10th July 2020. 
One woman was our booked case, 07 were booked, 
and referred cases from other public/private hospitals 
while 09 were non-booked. All women were Rhesus 
positive. Mean maternal age was 28.94 yrs (Range; 18-
39 yrs). Primigravida was 07, Multipara was 10. Mean 
gestational age at presentation was 37 wks (range; 30-
41wks) 06 (35%) preterm (<37 wks), 09 (53%) at 37-40 
wks and 02 (12%) at 41 wks. Presenting 
symptomatology was varied (Figure 1). Asymptomatic 
women had their COVID-19 test done because of some 
affected close contact. The commonest co-morbidity 
was Hypertensive disorders of pregnancy (Figure 2). 
Five patients (29%) required ICU admission, two 
needing high flow oxygen, and one with hepatic 
encephalopathy required ventilatory support as well. 
Ten women (59%) delivered by LSCS under regional 
spinal anaesthesia while 2 had general anaesthesia. 
Uneventful spontaneous vaginal deliveries were 07 
(41%) including one vaginal birth after caesarean 
(VBAC) and one case of induction of labour in a 
multiparous post-dated woman. Indications for LSCS 
are shown in Table 1. 
Maternal Pre-partum complications were encountered 
in 5 (29%) cases; Sepsis-02 (12%), Scar dehiscence-01 
(6%), Aspiration pneumonia-01 (6%), Hepatitis E 
Hepatic Encephalopathy-01 (6%). Post-partum 
complications were seen in 6 (35%) cases; Low O2 
saturation-02 (12%), Burst Abdomen-02 (12%), Sepsis-
01 (6%) and Typhoid fever- 01 (6%) 
The majority of babies (n=11) delivered alive with a 
good one minute Apgar score of 7-8. Liquor was clear 
and adequate in 10 cases and oligohydramnios in only 
one case. The other 6 cases had 3rd-degree meconium, 
out of which 2 expired in 1st week of life (ENND) and 
4 were received IUDs (Fig.03). Obstetric risk factors 
associated with fetal demise are shown in Table 2.  
Majority of babies (71%) had birth weight of 2.5-3.5 kg, 
24% of <2.5kg and 5% were >3.5kg. Breastfeeding was 
not established in any case during a hospital stay. Out 
of 13 live-born babies, RT-PCR Covid-19 testing was 
done in 10 (77%) and was negative, 02 babies had 
ENND, one was taken home and could not be tested. 
One mother was expired due to complications of 
hepatic encephalopathy, sepsis, and burst abdomen. 
Two mothers left against medical advice (LAMA), 
while the other 14 (82%) were discharged as per 
discharge criteria in stable condition.  
 
Figure 1: Symptomatology 
 
Figure 2: CO-Morbidities 
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Table 1: Indications for Caesarean Delivery 
Sr. 
# 
Indication Number/10 (%) 
01. Previous 01 LSCS 01 (10) 
02. Previous 02 LSCS 02 (20) 
03. Previous 03 LSCS 01 (10) 
04.  Chorio-amnionitis 02 (20) 
05. Precious Pregnancy & 
DM 
01 (10) 
06. CPD 01 (10) 
07. Fetal Distress 01 (10) 
08.  Eclampsia  01 (10) 
 










01 31 Eclampsia Meconium IUD 
02 34 Uterine Scar 
dehiscence 
Meconium IUD 
03 30 Hepatitis E 
Encephalopathy 
Meconium IUD 
04 36 Chorio-amnionitis Meconium IUD 
05 39 Chorio-amnionitis Meconium ENND 










In this case series study, we described the clinical 
characteristics, feto-maternal, and neonatal outcome in 
seventeen COVID-19 positive pregnant women. 
Overall results were reassuring. Pregnant women are 
more prone to respiratory infections due to 
immunosuppression.12 Studies are being carried out 
worldwide to explore the mutual effects of pregnancy 
and SARS-COV2 infection. Available data is scanty 
and controversial at this time. Very first study 
reporting the effect of COVID-19 infection on the feto-
maternal and neonatal outcome from China in March 
2020,5 concludes that COVID-19 contracted in 
advanced pregnancy have a good outcome. Multiple 
studies suggest that Clinical manifestation of COVID-
19 in pregnancy is not different from non-pregnant 
adults,14-17 yet according to few studies pregnancy can 
complicate the clinical course of COVID-19 
disease.5,14,18 The presenting symptomatology is 
diverse. An infected person can be asymptomatic at 
one end of the spectrum, going through mild common 
symptoms of fever, cough, sore throat, myalgias, 
fatigue 19-20 can culminate into severe complications of 
respiratory distress syndrome, cardiac injury, end-
organ failure or even death at the other end.14,17  
A recent report by the Center for Disease Control and 
Prevention (CDC)21 states that fever, muscle aches, 
chills, headache, and diarrhea are less reported among 
COVID-19 pregnant women than non-pregnant. In our 
study course of the disease was mainly mild and 
almost half of women were either asymptomatic (had 
COVID-19 test due to a close contact exposure) or they 
presented in labour with no COVID-19 specific 
symptoms. The main COVID-19 specific symptoms 
were fever and flu in 12% of women. Less common 
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were cough, myalgia, and shortness of breath. The 
commonest co-morbidity was a hypertensive disorder 
of pregnancy seen in 04 cases. The effect of COVID-19 
infection upon pregnancy outcome is also conflicting. 
Deleterious effects reported by few studies5,17,22 are 
miscarriage, fetal distress, fetal growth retardation, 
preterm labour, respiratory distress, 
thrombocytopenia, abnormal liver function, or even 
feto-maternal mortality yet another study20 gives no 
evidence of fetus distress. Our study reported no case 
of miscarriage, preterm labour or severe respiratory 
distress. 
Pro-inflammatory status of 1st and 3rd trimester and 
anti-inflammatory status of 2nd trimester of pregnancy 
is a fact.23,24 In our study all women were affected in 
the third trimester with overall satisfactory outcomes. 
Few other studies also reported good feto-maternal 
and neonatal outcomes in late pregnancy infection.5,17 
The one COVID-19 positive mother expired in our 
study had complications of hepatitis E-hepatic 
encephalopathy, postoperative sepsis, and burst 
abdomen.  
Mode of delivery is subjected to individual 
departmental policy owing to uncertainty about the 
risk of intrapartum mother-to-baby transmission by 
vaginal delivery. For the same concern and to 
minimize the exposure time of health personnel 
involved in women care we opted for a low threshold 
for caesarean delivery for COVID-19 positive women 
but those women who presented in the active phase 
and good progress of labour were encouraged to 
deliver vaginally. No caesarean delivery was done 
solely due to COVID-19 infection and there were 
strong obstetric indications for the LSCS. In a few 
studies, all affected mothers had an elective caesarean 
delivery.5,17 Another study reported that vaginal 
secretions are negative for this virus and vaginal 
delivery is a safe option.25 In our study women who 
delivered vaginally, their course of labour was not 
altered by the COVID-19 disease. There was one 
VBAC and even one induction of labour in a 
multiparous woman at 41 wks who successfully 
accomplished vaginal delivery. General anesthesia 
should be avoided and Spinal anesthesia is the choice 
for COVID-19 positive cases.26 We conducted all LSCS 
under spinal anaesthesia except two cases; one of 
eclampsia and another woman was in hepatic 
encephalopathy. The same two women required ICU 
admission, the other 3 women were admitted in ICU 
for oxygen demand and in just an anticipating of 
deterioration of their symptoms and had an 
uneventful recovery. Recently CDC reports21 that 
COVID-19 infected women are more prone to 
hospitalization, ICU admission, and needing 
mechanical ventilation than non-pregnant women, but 
their risk for death remains the same. A Sweden study 
also found that pregnant women with COVID-19 are 
five times more likely to be admitted in ICU and four 
times more prone to receive mechanical ventilation 
than non-pregnant women.27 
Regarding neonatal outcomes, the majority of our 
babies were delivered with good Apgar score and 
birth weight. Two babies of febrile mothers were 
delivered with 3rd-degree meconium and expired 
within 24 hrs while 4 were received IUDs. As shown 
in the results cause of fetal demise in such cases seems 
to be associated with some strong Obstetric risk factor. 
There is currently no report of vertical transmission of 
COVID-19 infection, and the barrier role of the 
placenta against viral and bacterial infections is a 
fact.24 However, increased expression of ACE2 
receptors over the placenta renders not only mothers 
more susceptible to COVID-19 but may also facilitate 
vertical transmission.10,28 Multiple studies give no 
evidence of vertical transmission.20,29,30 and in studies 
with women affected in the 3rd trimester, all babies 
born were negative for SARS-COV-2.5,17,31 Same was 
the result in our study. All 10 babies who made to life 
and were tested later on were COVID-19 negative. All 
these studies are small sampled and done in advanced 
pregnancy, evoking uncertainty about how this 
infection will affect the fetus in the first or second 
trimester.  
Breastfeeding by COVID-19 positive mothers is also 
not spared of controversy. In the early months of the 
pandemic, researchers suggested keeping neonates of 
suspected or confirmed COVID-19 diseased mothers 
isolated for at least two weeks after birth and not be 
breastfed.31,32 Another study reported that breast milk 
from affected mothers is free of SARS-COV2.17 Instead 
of such controversy our paediatric team refrained 
mothers from breastfeeding during active disease and 
babies were kept isolated. However, at times mothers 
were also given the option of expressed breast milk for 
a neonate or to even establish breastfeeding with 
adequate precautionary measures (handwashing, use 
of face masks) but mothers and family were too 
reluctant to establish breastfeeding due to anxiety of 
disease. The latest recommendation by CDC33 and 
WHO34 is now for breastfeeding, as available data is 
insufficient to conclude vertical transmission of 
COVID-19 through breastfeeding. Moreover, infants 
are at low risk for this infection which is typically mild 
or asymptomatic for them, while the consequences of 
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no breastfeeding and ‘mother-child bonding’ are 
significant. As benefits of breastfeeding outweigh the 
risks associated with COVID infection, breastfeeding 
should be initiated and continued with adherence to 
infection control measures by the mother, who in 
coordination with her family must also be involved in 
this decision making. 
 
Strengths of the Study 
 
Our study is perhaps the first one in the region 
reporting upon feto-maternal and neonatal outcome in 
pregnant women with COVID-19 infection. This case 
series reports upon 17 COVID-19 positive pregnant 
women and we could not find another research study 
in the literature (excluding review articles) reporting 
upon this many numbers of cases. The study results 
are genuine reflecting the selfless and dedicated health 
services by our obstetric department during this 
highly contagious pandemic and we hope our results 
will contribute to already gather a pool of information 
and will provide a framework to be adopted by other 
tertiary maternity hospitals managing pregnant 
women in this pandemic. 
 
Limitations of the Study 
 
Nevertheless, the study had few limitations. Firstly, as 
we reviewed medical charts so we could not get a long 
term to follow up on mother and baby. Secondly, it 
was a single centre study and sample size, as well as 
generalization of results, could have been improved 
by the multicenter study. Third, reviewed literature 
was mainly international and from developed 
countries, no local original study could be retrieved to 
relate to our results. Fourth, all studied cases were in 
the third trimester, and the effect of COVID-19 





Pregnancy represents a special vulnerable condition 
for any infectious disease. The clinical course of 
COVID-19 disease in pregnancy seems to be no 
different from non-pregnant women. Clinical 
manifestations are diverse and infection contracted in 
advanced pregnancy is associated with good feto-
maternal and neonatal outcomes. The vertical 
transmission of COVID-19 infection seems to be less 
likely and the decision for a mode of delivery should 
not be altered by this disease. Breastfeeding should be 
established with adequate infection control prevention 
measures. Obstetricians and maternity services 
providers must have updated knowledge according to 
evolving WHO guidelines for better maternal and 
neonatal care and the self-protection. To overcome the 
controversies several aspects of COVID-19 disease in 
pregnancy need to be explored with large sample-
sized multicenter studies. 
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